NOVO NORDISK A/S Toevoegen aan een lijst
|
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
| 886,6 DKK | +2,28% |
|
+2,36% | +27,00% |
| 25/04 | NOVO NORDISK : JP Morgan herhaalt koopadvies | ZD |
| 25/04 | Scholz belooft steun voor farmaceutische sector in Duitsland nu Merck investeert | RE |
Totale waarde
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Marktkapitalisatie 1 | 909.347 | 986.612 | 1.674.992 | 2.118.803 | 3.112.331 | 3.955.411 | - | - |
| Bedrijfswaarde 1 | 898.355 | 984.211 | 1.684.152 | 2.121.013 | 3.109.107 | 3.979.266 | 3.955.063 | 3.916.621 |
| K/w-verhouding | 23,6 x | 23,7 x | 35,4 x | 38,4 x | 37,5 x | 38,4 x | 31,6 x | 26,8 x |
| Dividendrendement | 2,16% | 2,13% | 1,41% | 1,32% | 1,35% | 1,33% | 1,59% | 1,84% |
| Marktkapitalisatie/omzet | 7,45 x | 7,77 x | 11,9 x | 12 x | 13,4 x | 13,8 x | 11,4 x | 9,91 x |
| Bedrijfswaarde/omzet | 7,36 x | 7,75 x | 12 x | 12 x | 13,4 x | 13,8 x | 11,4 x | 9,82 x |
| Bedrijfswaarde/EBITDA | 15,5 x | 16,4 x | 26 x | 25,8 x | 27,8 x | 28,5 x | 23 x | 19,3 x |
| Bedrijfswaarde/FCF | 26,1 x | 34,5 x | 57,4 x | 37 x | 45,5 x | 60,5 x | 40,1 x | 32,4 x |
| FCF Yield | 3,83% | 2,9% | 1,74% | 2,7% | 2,2% | 1,65% | 2,49% | 3,09% |
| Price to Book | 15,8 x | 15,8 x | 24 x | 25,6 x | 29,4 x | 26,8 x | 20,4 x | 15,7 x |
| Aantal aandelen (in duizenden) | 4.703.720 | 4.624.923 | 4.557.801 | 4.517.704 | 4.458.288 | 4.461.326 | - | - |
| Referentieprijs 2 | 193,3 | 213,3 | 367,5 | 469,0 | 698,1 | 886,6 | 886,6 | 886,6 |
| Datum van publicatie | 05-02-20 | 03-02-21 | 02-02-22 | 01-02-23 | 31-01-24 | - | - | - |
1DKK in Miljoen2DKK
Geschatte gegevens
Evolutie van de resultatenrekening (Jaargegevens)
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 122.021 | 126.946 | 140.800 | 176.954 | 232.261 | 287.397 | 345.722 | 398.941 |
| EBITDA 1 | 58.144 | 59.879 | 64.669 | 82.171 | 111.987 | 139.658 | 172.071 | 202.591 |
| Bedrijfsresultaat (EBIT) 1 | 52.483 | 54.126 | 58.644 | 74.809 | 102.574 | 129.112 | 157.931 | 186.518 |
| Operationele Marge | 43,01% | 42,64% | 41,65% | 42,28% | 44,16% | 44,92% | 45,68% | 46,75% |
| Resultaat voor belastingen (EBT) 1 | 48.553 | 53.130 | 59.080 | 69.062 | 104.674 | 129.951 | 157.771 | 185.815 |
| Nettowinst (verlies) 1 | 38.951 | 42.138 | 47.757 | 55.525 | 83.683 | 103.570 | 124.834 | 146.329 |
| Nettomarge | 31,92% | 33,19% | 33,92% | 31,38% | 36,03% | 36,04% | 36,11% | 36,68% |
| WPA 2 | 8,190 | 9,005 | 10,37 | 12,22 | 18,62 | 23,12 | 28,06 | 33,05 |
| Free Cash Flow 1 | 34.451 | 28.565 | 29.319 | 57.362 | 68.326 | 65.793 | 98.551 | 120.884 |
| FCF-marge | 28,23% | 22,5% | 20,82% | 32,42% | 29,42% | 22,89% | 28,51% | 30,3% |
| Kasstroomconversie (ebitda) | 59,25% | 47,7% | 45,34% | 69,81% | 61,01% | 47,11% | 57,27% | 59,67% |
| Kasstroomconversie (nettowinst) | 88,45% | 67,79% | 61,39% | 103,31% | 81,65% | 63,53% | 78,95% | 82,61% |
| Dividend per aandeel 2 | 4,175 | 4,550 | 5,200 | 6,200 | 9,400 | 11,76 | 14,08 | 16,34 |
| Datum van publicatie | 05-02-20 | 03-02-21 | 02-02-22 | 01-02-23 | 31-01-24 | - | - | - |
1DKK in Miljoen2DKK
Geschatte gegevens
Evolutie van de resultatenrekening (Kwartaalgegevens)
| Fiscaal tijdperk: december | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet 1 | 35.622 | 38.333 | 42.301 | 41.265 | 45.566 | 48.092 | 53.367 | 54.300 | 58.731 | 65.863 | 63.573 | 67.508 | 72.658 | 81.307 | 77.406 |
| EBITDA 1 | 16.598 | 15.716 | 20.797 | 20.027 | 22.225 | 19.122 | 26.726 | 26.065 | 29.438 | 29.758 | 31.300 | 33.760 | 36.658 | 38.905 | 37.297 |
| Bedrijfsresultaat (EBIT) 1 | 15.249 | 13.634 | 19.147 | 18.391 | 20.184 | 17.087 | 25.007 | 23.888 | 26.913 | 26.766 | 28.694 | 30.122 | 33.334 | 36.043 | 35.116 |
| Operationele Marge | 42,81% | 35,57% | 45,26% | 44,57% | 44,3% | 35,53% | 46,86% | 43,99% | 45,82% | 40,64% | 45,13% | 44,62% | 45,88% | 44,33% | 45,37% |
| Resultaat voor belastingen (EBT) 1 | 15.112 | 13.113 | 17.919 | 16.795 | 18.032 | 16.316 | 24.737 | 24.254 | 28.063 | 27.620 | 28.630 | 30.288 | 33.794 | 36.383 | 35.182 |
| Nettowinst (verlies) 1 | 12.119 | 10.892 | 14.210 | 13.318 | 14.405 | 13.592 | 19.814 | 19.428 | 22.478 | 21.963 | 23.169 | 24.178 | 26.964 | 28.328 | 28.254 |
| Nettomarge | 34,02% | 28,41% | 33,59% | 32,27% | 31,61% | 28,26% | 37,13% | 35,78% | 38,27% | 33,35% | 36,45% | 35,81% | 37,11% | 34,84% | 36,5% |
| WPA 2 | 2,635 | 2,380 | 3,110 | 2,930 | 3,170 | 3,010 | 4,390 | 4,315 | 5,000 | 4,910 | 5,185 | 5,425 | 6,044 | 6,290 | 15,10 |
| Dividend per aandeel 2 | - | 3,450 | - | 2,125 | - | 4,075 | - | 3,000 | - | 6,400 | 2,932 | 3,491 | 2,932 | 5,191 | 3,714 |
| Datum van publicatie | 03-11-21 | 02-02-22 | 29-04-22 | 03-08-22 | 02-11-22 | 01-02-23 | 04-05-23 | 10-08-23 | 02-11-23 | 31-01-24 | - | - | - | - | - |
1DKK in Miljoen2DKK
Geschatte gegevens
Balans
| Fiscaal tijdperk: december | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Nettoschuldpositie 1 | - | - | 9.160 | 2.210 | - | 23.854 | - | - |
| Nettokaspositie 1 | 10.992 | 2.401 | - | - | 3.224 | - | 348 | 38.790 |
| Hefboom (schuld/ebitda) | - | - | 0,1416 x | 0,0269 x | - | 0,1708 x | - | - |
| Free Cash Flow 1 | 34.451 | 28.565 | 29.319 | 57.362 | 68.326 | 65.793 | 98.551 | 120.884 |
| ROE (netto-inkomsten/eigen vermogen) | 71,2% | 69,7% | 71,2% | 72% | 88,1% | 82,3% | 92,1% | 84,7% |
| ROA (netto-inkomsten/totale activa) | 33% | 31,2% | 28,1% | 25,5% | 30,1% | 28,3% | 29% | 31,2% |
| Totale activa 1 | 118.191 | 135.267 | 169.715 | 217.883 | 277.872 | 365.333 | 430.306 | 468.338 |
| Nettoactief per aandeel 2 | 12,20 | 13,50 | 15,30 | 18,30 | 23,80 | 33,00 | 43,50 | 56,50 |
| Cashflow per aandeel 2 | 9,840 | 11,10 | 11,90 | 17,40 | 24,20 | 22,90 | 27,40 | 31,20 |
| Capex 1 | 8.932 | 5.825 | 6.335 | 12.146 | 25.806 | 45.093 | 42.535 | 42.603 |
| Capex/omzet | 7,32% | 4,59% | 4,5% | 6,86% | 11,11% | 15,69% | 12,3% | 10,68% |
| Datum van publicatie | 05-02-20 | 03-02-21 | 02-02-22 | 01-02-23 | 31-01-24 | - | - | - |
1DKK in Miljoen2DKK
Geschatte gegevens
WPA & Dividend
Historische koers/winstverhouding
Evolutie van de historische prestaties
Historische marktkapitalisatie/EBITDA
Trading rating
Beleggingsrating
ESG Refinitiv
B
Verkoop
Koop
Gemiddeld advies
Accumuleren
Aantal analisten
25
Laatste slotkoers
886,6
DKK
Gemiddelde koersdoel
904,2
DKK
Spread / Gemiddelde doel
+1,99%
Herzieningen van WPA
| Vaira. 1 jan. | Kapi. | |
|---|---|---|
| +27,00% | 566 mld. | |
| +25,83% | 661 mld. | |
| -6,76% | 352 mld. | |
| +20,34% | 332 mld. | |
| +3,00% | 283 mld. | |
| +13,09% | 231 mld. | |
| +5,46% | 200 mld. | |
| -9,61% | 195 mld. | |
| -6,26% | 145 mld. | |
| -11,77% | 144 mld. |
- Beurs
- Aandelen
- Koers NOVO B
- Financiën Novo Nordisk A/S
